Award
National Heart, Lung, and Blood Institute 1R41HL172481-01
Develop natural compound emodin as a novel therapy for calcific aortic valve disease
Recipient
Mohamad Azhar
Award Amount
$299,953.00
Ceiling
$299,953.00
Awarded
September 16, 2024
Identifier
1R41HL172481-01
Award to develop emodin as a novel therapy for calcific aortic valve disease, involving preclinical studies and preparation for human trials.
Description
This project aims to develop emodin as a therapy for calcific aortic valve disease, including in vivo and in vitro studies, with plans for further large animal testing and manufacturing for human trials.